SII Founder Dr Cyrus Poonawalla Undergoes Angioplasty Due to Heart Attack

Dr Cyrus S. Poonawalla, the founder of the Serum Institute of Indian (SII), was admitted to in the city on Thursday following a heart attack.

Senior representatives from SII and the Dr. Cyrus S. Poonawalla hospital verified the development and stated that Dr. Poonawalla was stable at the time.

Currently serving as managing director and chair of SII, Dr. Poonawalla was instrumental in the mass manufacturing of the Covishield vaccine against Covid-19 during the pandemic.

Dr Cyrus Poonawalla was admitted to Ruby Hall Clinic on November 16 after suffering a mild myocardial infarction in the morning, according to an advisor for the clinic. He had an angioplasty on November 17 under Dr. Purvez Grant’s supervision. He is healing quickly, so by Sunday he should be released. The health of Dr. Poonawalla is good.

An angioplasty is a procedure used to clear coronary arteries that have become clogged due to coronary artery disease. It is performed in an emergency situation, like a heart attack, and restores blood flow to the heart muscle without requiring open heart surgery.

Dr Cyrus Poonawalla established the Serum Institute of India in 1966 with the intention of producing immuno-biologicals that could save lives, as they were expensively imported and in short supply in the nation.

Shreyas Vange